Stelara Injection 130 mg/26 ml

Stelara (Ustekinumab)

Ustekinumab under the trade name  Stelara (also known as CNTO 1275) is an immunosuppressant used to treat plaque psoriasis, psoriatic arthritis, and Crohn’s disease. Ustekinumab as the first biologic therapy for Crohn’s disease is the only treatment for Crohn’s disease that starts with a weight-based, one-time intravenous (IV) infusion induction dose.

Continue reading

Remicade

Remicade (Infliximab)

The trade name of Infliximab is Remicade. This biologic drug is used for the treatment of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis and also used off-label outside its FDA approval for Behcet's disease and other conditions. Remicade is the first approved TNF-alpha inhibitor available in the U.S.  Remicade infusion therapy is used to treat Crohn's disease, ulcerative colitis, and rheumatoid arthritis. Stomach...

Continue reading